18F-FDG PET/CT 在疑似软骨肉瘤复发患者诊断与预后评估中的应用
回顾性分析31例既往治疗患者(46次检查)的FDG PET/CT,评价其对复发软骨肉瘤的诊断与预后价值。复发(局部和远处)在46次检查中占28次(60.8%),灵敏度和特异度分别为88.9%和78.9%。复发原发部位FDG摄取和肿瘤分级是疾病特异性生存的可靠预后因素,两者联合可改善生存预测。
要点
- 46次FDG PET/CT中28次(60.8%)显示复发(局部和远处),灵敏度88.9%、特异度78.9%。
- 3个肿瘤分级组间复发原发部位中位SUVmax差异有统计学意义(P=0.008),分级越高中位SUVmax越高。
- 复发原发部位SUVmax截断值6.15时平均DSS时间差异有统计学意义(P<0.001)。
核心结论
- 在复发软骨肉瘤中,复发原发部位FDG摄取和肿瘤分级是疾病特异性生存的可靠预后因素。
- PET/CT在复发场景中有预测肿瘤分级和生存的潜力,可能有助于临床管理。
研究设计与样本
- 回顾性分析31例既往治疗患者的FDG PET/CT表现,共46次检查,自首次PET/CT检查之日起平均随访40.7±23.9个月(范围3-77个月)。
- 采用Kaplan-Meier法进行DSS分析,参数包括肿瘤分级、复发原发部位FDG摄取以及分级与FDG摄取的组合。
主要发现
- 46次FDG PET/CT检查中28次(60.8%)显示复发(局部和远处),灵敏度和特异度分别为88.9%和78.9%。
- 3个肿瘤分级组间复发原发部位中位SUVmax差异有统计学意义(P=0.008),分级越高中位SUVmax越高。
- 不同分级组间中位SUVmax差异有统计学意义,但II级与III级之间除外。
- 由受试者工作特征曲线得出的复发原发部位SUVmax截断值6.15时平均DSS时间差异有统计学意义(P<0.001)。
- 3个不同肿瘤分级组间生存差异有统计学意义(P=0.016),SUVmax与分级联合较单用分级改善生存预测。
临床怎么用
- 作者认为,PET/CT在复发场景中有预测肿瘤分级和生存的潜力,可能有助于临床管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of the study was to analyze the diagnostic and prognostic utility of F-FDG PET/CT to predict the disease-specific survival (DSS) with FDG uptake and tumor grade in recurrent chondrosarcoma. METHODS: Retrospective analysis of FDG PET/CT findings in 31 previously treated patients (46 studies) with mean follow-up period of 40.7 ± 23.9 months (range, 3-77 months) from the date of first PET/CT study was done. Kaplan-Meier DSS analysis was made with respect to tumor grade, FDG uptake at the recurrent primary sites, and a combination of grade and FDG uptake as parameters. RESULTS: Recurrence (local and distant) was shown in 28 (60.8%) of 46 FDG PET/CT studies with sensitivity and specificity of 88.9% and 78.9%, respectively. The median SUVmax at the recurrent primary sites differed significantly (P = 0.008) among 3 tumor grade groups, with higher median SUVmax in higher grades. There was significant difference in median SUVmax among different grade groups except between grade II and grade III. Recurrent primary site SUVmax cutoff at 6.15 derived from the receiver operating characteristic curve yielded significant difference (P < 0.001) in mean DSS time. Significant difference in survival was noted between 3 different tumor grade groups (P = 0.016). The combination of SUVmax and grade improved the survival prediction than with grade alone. CONCLUSIONS: In recurrent chondrosarcoma, the recurrent primary site FDG uptake and grade were found to be reliable prognostic factors with respect to DSS. PET/CT in recurrence setting has the potential to predict tumor grade and survival and may assist in clinical management.
引用
- Vadi SK, Mittal BR, Gorla AKR, et al. 18F-FDG PET/CT in Diagnostic and Prognostic Evaluation of Patients With Suspected Recurrence of Chondrosarcoma. Clin Nucl Med. 2018. PMID: 29261626. doi:10.1097/RLU.0000000000001947
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。